GROUP ONE TRADING, L.P. - NPS PHARMACEUTICALS INC ownership

NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 193 filers reported holding NPS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of NPS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$3,766,000
+3864.2%
105,286
+2779.0%
0.06%
+5600.0%
Q3 2014$95,000
-90.4%
3,657
-88.9%
0.00%
-94.1%
Q1 2014$987,000
-56.7%
32,971
-56.1%
0.02%
-50.0%
Q4 2013$2,282,000
-42.3%
75,154
-39.6%
0.03%
-55.3%
Q3 2013$3,956,000
+1151.9%
124,355
+493.4%
0.08%
+850.0%
Q2 2013$316,00020,9550.01%
Other shareholders
NPS PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
HARVEY CAPITAL MANAGEMENT INC 549,425$16,680,0006.89%
Opaleye Management Inc. 205,000$5,945,000,0004.67%
Rhenman & Partners Asset Management AB 240,000$7,286,0002.85%
SECTORAL ASSET MANAGEMENT INC 1,774,919$53,887,0002.32%
Eventide Asset Management 242,700$7,368,0002.27%
OAK RIDGE INVESTMENTS LLC 2,713,717$82,389,0002.16%
First Light Asset Management, LLC 68,245$2,072,0001.76%
Broadfin Capital, LLC 400,000$12,144,0001.60%
Cupps Capital Management, LLC 748,175$22,714,0001.54%
FCG ADVISORS, LLC 70,651$2,145,0001.45%
View complete list of NPS PHARMACEUTICALS INC shareholders